Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.
UK Launches AI Trial to Enhance Early Breast Cancer Detection
Health Secretary Wes Streeting has unveiled a pioneering trial that leverages artificial intelligence to improve the early detection of breast cancer, a disease affecting tens of thousands of women each year in the UK.
The ambitious project, involving nearly 700,000 participants across 30 testing sites nationwide, will integrate AI technology with mammogram screenings to identify subtle changes in breast tissue that may indicate cancer.
Revolutionising Mammogram Screening with AI
Currently, mammogram readings require the expertise of two radiologists to ensure accuracy. However, the Department of Health and Social Care anticipates that AI could enable a single specialist to perform screenings, enhancing efficiency and reliability.
If successful, this trial could significantly reduce radiologists’ workload, freeing them to conduct additional vital tests and potentially decrease patient wait times for screenings.
A Health Secretary’s Personal Call to Action
In an exclusive opinion piece for The Independent, Streeting shared his personal journey with cancer, underscoring the importance of early detection. His experience highlights the need for improved healthcare systems and reveals the current struggles patients face.
Streeting says, “Had that meticulous doctor not spotted my cancer on the X-ray, I may not be here today. Yet I know sadly many cancer patients don’t experience the NHS at its best.”
He acknowledges the ongoing issues within the NHS, such as long wait times and delayed diagnoses, urging for a comprehensive solution to these critical gaps in care.
NIHR Invests £11m in EDITH Trial
The National Institute for Health and Care Research (NIHR) is committing £11 million to fund the Early Detection using Information Technology in Health (EDITH) trial. This investment underscores the government’s commitment to advancing healthcare technology.
Professor Lucy Chappell, NIHR’s chief executive and the Department of Health and Social Care’s chief scientific adviser, expressed optimism about the trial’s potential impact. She stated, “This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.”
Expert Opinions on AI in Cancer Detection
Dr Katharine Halliday, president of the Royal College of Radiologists, sees AI as a game-changer in diagnostics and cancer care. She believes government investment is crucial for realising the technology’s full potential.
Halliday notes, “Given the volume and complexity of breast screening, if AI is found to be safe and effective it could make a major impact on radiology.” However, she cautions that rigorous testing and clinical oversight are essential to ensure AI’s safe implementation.
She adds, “With a projected 40 per cent shortfall in consultant radiologists by 2028, the need to build radiology capacity remains urgent.”
The National Cancer Plan and Beyond
Breast cancer is the most common cancer diagnosed in UK women, with around 55,000 cases each year. The national breast screening programme invites women over 50 to get screened every three years, completing approximately 2.1 million screens annually.
Breast Cancer Now’s chief executive, Claire Rowney, welcomes the government’s focus on improving breast cancer detection. She emphasizes the need for a robust workforce, updated IT systems, and comprehensive support frameworks to ensure successful integration of AI into healthcare practices.
Rowney says, “However, while new innovations and technologies have the potential to improve breast screening, there are fundamental issues in the breast-screening programme right now that must be addressed in order for them to be rolled out successfully.”
Cancer Research UK Weighs In
Samantha Harrison, head of strategic evidence at Cancer Research UK, views the trial as a pivotal step in reducing pressure on the NHS and decreasing waiting lists.
Harrison notes, “It’s important to remember that cancer screening is for people without symptoms, though, so if you’ve noticed any changes that aren’t normal for you, don’t wait for your next screening invite, talk to your doctor. It probably won’t be cancer, but if it is, spotting it early means that treatment is more likely to be successful.”
Government Seeks Expert Input
The government is also inviting cancer experts, medical professionals, and survivors to contribute evidence and experiences as part of a comprehensive call for evidence to develop the National Cancer Plan. This plan aims to improve survival rates and patient care.
The plan, set for publication later this year,